Gene · 7049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KIF6 Trp719Arg Genetic Variant Increases Risk for Thoracic Aortic Dissection. | Genes (Basel) | 2023 | 36833179 | PubTator, text mining | PubMed |
| Role of PI3K-AKT Pathway in Ultraviolet Ray and Hydrogen Peroxide-Induced Oxidative Damage and Its Repair by Grain Ferments. | Foods | 2023 | 36832881 | PubTator, text mining | PubMed |
| MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer. | Cancers (Basel) | 2023 | 36831632 | PubTator, text mining | PubMed |
| Bacteria and macrophages in the tumor microenvironment. | Front Microbiol | 2023 | 36825088 | PubTator, text mining | PubMed |
| circRNA, a novel diagnostic biomarker for coronary heart disease. | Front Cardiovasc Med | 2023 | 36818340 | PubTator, text mining | PubMed |
| Roles of TGF‑β signalling pathway‑related lncRNAs in cancer (Review). | Oncol Lett | 2023 | 36817052 | PubTator, text mining | PubMed |
| Bioinformatics analysis identifies heparan sulfate proteoglycans acting as different progress subtypes of biliary atresia. | Front Pediatr | 2023 | 36816373 | PubTator, text mining | PubMed |
| The expanding spectrum and utility of antigens in membranous nephropathy. | Curr Opin Nephrol Hypertens | 2023 | 36811646 | PubTator, text mining | PubMed |
| Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application. | Mol Cancer | 2023 | 36810071 | PubTator, text mining | PubMed |
| Genetics of migraine: where are we now? | J Headache Pain | 2023 | 36800925 | PubTator, text mining | PubMed |
| Exhaustion‑like dysfunction of T and NKT cells in an X‑linked severe combined immunodeficiency patient with maternal engraftment by single‑cell analysis. | Int J Mol Med | 2023 | 36799159 | PubTator, text mining | PubMed |
| Development of a TGF-β signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma. | Front Oncol | 2023 | 36776317 | PubTator, text mining | PubMed |
| Precision Medicine in Glaucoma: Artificial Intelligence, Biomarkers, Genetics and Redox State. | Int J Mol Sci | 2023 | 36769127 | PubTator, text mining | PubMed |
| Glypican-4 regulated actin cytoskeletal reorganization in glucocorticoid treated trabecular meshwork cells and involvement of Wnt/PCP signaling. | J Cell Physiol | 2023 | 36727620 | PubTator, text mining | PubMed |
| KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers? | Cancer Metastasis Rev | 2023 | 36720764 | PubTator, text mining | PubMed |
| PCV2 Uptake by Porcine Monocytes Is Strain-Dependent and Is Associated with Amino Acid Characteristics on the Capsid Surface. | Microbiol Spectr | 2023 | 36719220 | PubTator, text mining | PubMed |
| Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma. | Cell Biosci | 2023 | 36717896 | PubTator, text mining | PubMed |
| Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer. | J Exp Clin Cancer Res | 2023 | 36717865 | PubTator, text mining | PubMed |
| A Comprehensive Exploration of the Transcriptomic Landscape in Multiple Sclerosis: A Systematic Review. | Int J Mol Sci | 2023 | 36674968 | PubTator, text mining | PubMed |
HS, an Ancient Molecular Recognition and Information Storage Glycosaminoglycan, Equips HS-Proteoglycans with Diverse Matrix and Cell-Interactive Properties Operative in Tissue Development and Tissue Function in Health and Disease. | Int J Mol Sci | 2023 | 36674659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7049/papers?page=18